CVE:LXG - Lexagene Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$1.24 +0.04 (+3.33 %)
(As of 05/22/2018 11:45 AM ET)
Previous CloseC$1.20
Today's RangeC$1.21 - C$1.24
52-Week RangeC$0.49 - C$1.64
Volume20,678 shs
Average Volume68,777 shs
Market CapitalizationC$63.63 million
P/E RatioN/A
Dividend YieldN/A
Beta-5.14

About Lexagene (CVE:LXG)

Lexagene Holdings Inc. engages in the research, development, and commercialization of pathogen detection devices to the bio-chemical industry in the United States. The company is headquartered in Vancouver, Canada.

Receive LXG News and Ratings via Email

Sign-up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolCVE:LXG
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares54,200,000

Lexagene (CVE:LXG) Frequently Asked Questions

What is Lexagene's stock symbol?

Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LXG."

Who are some of Lexagene's key competitors?

Who are Lexagene's key executives?

Lexagene's management team includes the folowing people:
  • Dr. John F. Regan, Founder, Chairman & CEO
  • Mr. Darrel M. Rebeck, Pres & Director
  • Mr. Jeffrey Mitchell, Chief Financial Officer
  • Mr. Allan Fabbro, VP of Corp. Devel.
  • Mr. Greg Dale, VP of Product Devel. & Manufacturing

Has Lexagene been receiving favorable news coverage?

Headlines about LXG stock have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Lexagene earned a media sentiment score of 0.18 on Accern's scale. They also gave media headlines about the company an impact score of 45.49 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Lexagene?

Shares of LXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Lexagene's stock price today?

One share of LXG stock can currently be purchased for approximately C$1.24.

How big of a company is Lexagene?

Lexagene has a market capitalization of C$63.63 million.


MarketBeat Community Rating for Lexagene (LXG)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  21
MarketBeat's community ratings are surveys of what our community members think about Lexagene and other stocks. Vote "Outperform" if you believe LXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LXG will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lexagene (CVE:LXG) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/22/2016 forward)

Earnings

Dividends

Lexagene (CVE:LXG) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Lexagene (CVE LXG) Insider Trading and Institutional Ownership History

Insider Trading History for Lexagene (CVE:LXG)

Lexagene (CVE LXG) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/26/2018John ReganInsiderBuy1,050C$1.05C$1,102.50
1/17/2018Daryl RebeckDirectorBuy10,000C$1.02C$10,200.00
(Data available from 1/1/2013 forward)

Headlines

Lexagene (CVE LXG) News Headlines

Source:

SEC Filings

Lexagene (CVE:LXG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Lexagene (CVE LXG) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.